Moores Lisa K, Collen Jacob F, Woods Kevin M, Shorr Andrew F
Pulmonary and Critical Care Medicine Service, Walter Reed Army Medical Center, Building 2, WD 77, 6900 Georgia Avenue NW, Washington, DC 20307-5001, USA.
Thromb Res. 2004;113(1):1-6. doi: 10.1016/j.thromres.2004.01.011.
In an attempt to standardize clinicians' approach to the determination of pretest probability (PTP) in pulmonary embolism (PE), two simplified scoring models have recently been proposed. We sought to determine the utility of these algorithms in patients with suspected PE in a large, tertiary, academic medical center.
We performed a retrospective analysis of 295 inpatients and outpatients from our institution who were evaluated for suspected PE. Pretest probability (PTP) was calculated using two previously formulated scoring systems by Wells et al. (Canadian score) and Wicki et al. (Geneva score). Our primary endpoint was the prevalence of PE within each strata of PTP.
The prevalence of pulmonary embolism in our cohort was 30%. The prevalence of PE in the low, intermediate and high PTP groups using the Canadian score was 15.3% (95% CI 9.5-23.7%), 34.8% (95% CI 27.9-42.4%), and 47.2% (95% CI 32.0-63.0), respectively. When compared with the low PTP group, the odds ratios of the likelihood of PE was 2.95 (95% CI 1.56-5.59) in the intermediate PTP group and 4.95 (95% CI 2.11-11.64) in the high PTP. The Wicki analysis was divided into "Geneva pure" and "Geneva presumed", where the fractional inspired oxygen concentration was known and presumed to have been sampled on room air, respectively. Neither of the Geneva scores showed statistical significance in the prevalence of PE among the PTP groups.
The Wells' clinical prediction score is easily applied and meaningfully risk stratifies patients with suspected PE. In our population, the Geneva score was less useful.
为使临床医生在确定肺栓塞(PE)的验前概率(PTP)时采用标准化方法,最近提出了两种简化评分模型。我们试图在一家大型三级学术医疗中心确定这些算法在疑似PE患者中的效用。
我们对本院295例接受疑似PE评估的住院和门诊患者进行了回顾性分析。使用Wells等人先前制定的两个评分系统(加拿大评分)和Wicki等人(日内瓦评分)计算验前概率(PTP)。我们的主要终点是PTP各分层中PE的患病率。
我们队列中肺栓塞的患病率为30%。使用加拿大评分,低、中、高PTP组中PE的患病率分别为15.3%(95%CI 9.5 - 23.7%)、34.8%(95%CI 27.9 - 42.4%)和47.2%(95%CI 32.0 - 63.0)。与低PTP组相比,中PTP组PE发生可能性的优势比为2.95(95%CI 1.56 - 5.59),高PTP组为4.95(95%CI 2.11 - 11.64)。Wicki分析分为“日内瓦纯合子”和“日内瓦推定”,分别是已知吸入氧分数浓度和假定在室内空气中采样的情况。在PTP组中,两种日内瓦评分在PE患病率方面均未显示出统计学意义。
Wells临床预测评分易于应用,能对疑似PE患者进行有意义的风险分层。在我们的研究人群中,日内瓦评分的作用较小。